Enrolling
These studies are actively looking for and accepting new participants who meet the study’s inclusion criteria.
-
CTN 324: Assessing the efficacy of an HPV vaccine in preventing anal pre-cancers in men living with HIV
A multicenter, randomized controlled trial of the efficacy, safety and immunogenicity of the 9-valent human papillomavirus (HPV) vaccination in preventing recurrence of high-grade anal dysplasia in HIV-positive men who have sex with men (MSM)
-
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.v
Learn More